CJC-1295 (No DAC) vs Ipamorelin

A GHRH analogue versus a selective GHRP. Here is how the two research peptides compare on class, format and price.

CJC-1295 (No DAC)

CJC-1295 without DAC (Mod GRF 1-29) is a synthetic analogue of growth-hormone-releasing hormone. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

CJC-1295 (No DAC) is studied for GHRH-receptor signalling and is frequently researched alongside the GHRP peptide Ipamorelin, with which it is often combined.

Ipamorelin

Ipamorelin is a synthetic selective growth-hormone-releasing peptide (GHRP). It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

Ipamorelin is studied for selective ghrelin/GHS-receptor activity and is commonly researched together with the GHRH analogue CJC-1295.

Which do researchers choose?

CJC-1295 (No DAC) and Ipamorelin are a GHRH analogue versus a selective GHRP. The right choice depends on the research question: they differ in class (Mod GRF (1-29) GHRH analogue vs Selective GHRP) and strength (10 mg vs 10 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.

Frequently asked questions